Prognostic factors in chronic obstructive pulmonary disease;Factores pronósticos en la EPOC

Archivos de Bronconeumologia

Volumn 43, Issue 12, 2007, Pages 680-691

  Cataluña, Juan José Soler ^a   García, Miguel Ángel Martínez ^a  

^a HOSPITAL GENERAL DE REQUENA   (Spain)

Author keywords

COPD; Predictors of mortality; Prognostic factors

Indexed keywords

CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; LIFE EXPECTANCY; LUNG FUNCTION; PATHOGENESIS; PROGNOSIS; REVIEW; SYMPTOM; TREATMENT INDICATION;

EID: 39749194133     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(07)60155-4     Document Type: Review

References (140)

1. NR Anthonisen EC Wright JE Hodgkin Prognosis in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 14 20
2. T Oga K Nishimura M Tsukino S Sato T Hajiro Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status Am J Respir Crit Care Med 167 2003 544 549
3. JJ Soler-Cataluña MA Martínez-García P Sánche Románz Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease Thorax 60 2005 925 931
4. K Nishimura T Izumi M Tsukino T Oga on behalf of the Kansai COPD Registry and Research Group in Japan Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD Chest 121 2002 1434 1440
5. AF Connors NV Dawson C Thomas FE Harrell N Desbiens WJ Fulkerson Outcomes following acute exacerbation of severe chronic obstructive lung disease Am J Respir Crit Care Med 154 1996 959 967
6. KH Groenewegen AMWJ Schols E Wouters Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD Chest 124 2003 459 467
7. RA Antonelli-Incalzi L Fuso M De Rosa E Rapiti B Nardecchia R Pistelli Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease Eur Respir J 10 1997 2794 2800
8. AM Yohannes MJ Connolly Effect of dichotomising age in multivariate model analysis Thorax 61 2006 548
9. P Almagro E Calbo A Ochoa de Echagüen B Barreiro S Quintana JL Heredia Mortality after hospitalization for COPD Chest 121 2002 1441 1448
10. RM Davis TE Novotny Changes in risk factors: the epidemiology of cigarette smoking on chronic obstructive pulmonary disease Am Rev Respir Dis 140 1989 S82 S84
11. Y Chen SL Horne JA Dosman Increased susceptibility to lung dysfunction in female smokers Am Rev Respir Dis 143 1991 1224 1230
12. E Prescott AM Bjerg PK Andersen P Lange J Vestbo Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study Eur J Respir J 10 1997 822 827
13. MC Machado JA Krishnan SA Buist AL Bilderback GP Fazolo MG Santarosa Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 174 2006 524 529
14. DM Mannino DE Doherty BA Sonia Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study Respir Med 100 2006 115 122
15. K Strom Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy Am Rev Respir Dis 147 1993 585 591
16. Medical Research Council Working Party Report of long-term oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Lancet 36 1981 752 758
17. Nocturnal Oxygen Therapy Trial Group Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease Ann Intern Med 93 1980 391 398
18. E Chailleux J-P Laaban D Veale Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from ANTADIR observatory Chest 123 2003 1460 1466
19. D Mannino Women and chronic obstructive pulmonary disease. Does sex influence survival? Am J Respir Crit Care Med 174 2006 488 489
20. F di Marco M Verga M Reggente CF Maria P Santus F Blasi Anxiety and depression in COPD patients: the roles of gender and disease severity Respir Med 100 2006 1767 1774
21. MA Vermeeren EC Creutzberg AM Schols DS Postma WR Pieters Prevalence of nutritional depletion in a large out-patient population of patients with COPD Respir Med 100 2006 1349 1355
22. RA Pauwels AS Buist PM Calverley CR Jenkings SS Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLB/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary Am J Respir Crit Care Med 163 2001 1256 1276
23. RE Kanner JE Connett DE Williams AS Buist for the Lung Health Study Research Group Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in the Lung Health Study Am J Med 106 1999 410 416
24. JI Granda-Orive JM Martínez-Albiach Deshabituación tabáquica en la EPOC Arch Bronconeumol 41 2005 625 633
25. NR Anthonisen MA Skeans RA Wise J Manfreda RE Kanner JE Connett The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial Ann Intern Med 142 2005 233 239
26. R Albalak AR Frisancho GJ Keeler Domestic biomass fuel combustion and chronic bronchitis in two rural Bolivian villages Thorax 54 1999 1404 1408
27. A Ramírez-Venegas RH Sansores R Pérez-Padilla J Regalado A Velázquez C Sánchez Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco Am J Respir Crit Care Med 173 2006 393 397
28. BR Celli W MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
29. B Burrows RH Earle Prediction of survival in patients with chronic airway obstruction Am Rev Respir Dis 99 1969 865 871
30. GA Traver MG Cline B Burrows Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study Am Rev Respir Dis 119 1979 895 902
31. NR Anthonisen Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials Am Rev Respir Dis 140 1989 S95 S99
32. DM Mannino AS Buist TL Petty PL Enright SC Redd Lung function and mortality in the United States: data from the first National Health and Nutrition Examination Survey Follow Up study Thorax 58 2003 388 393
33. CM Fletcher R Peto C Tinker FE Speizer The natural history of chronic bronchitis and emphysema 1976 Oxford University Press New York, Toronto
34. 1. The Lung Health Study JAMA 272 1994 1497 1505
35. JC Hogg F Chu S Utokaparch R Woods WM Elliot L Buzatu The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2004 2645 2653
36. PS Burge PMA Calverley PW Jones S Spencer JA Anderson TK Maslen on behalf of the ISOLDE study investigators Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease; the ISOLDE trial BMJ 320 2000 1297 1303
37. RA Pauwels CG Lofdahl LA Laitinen JP Schouten DS Postma NB Pride Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease N Engl J Med 340 1999 1948 1953
38. J Vestbo T Sorensen P Lange A Brix P Torre K Viskum Long- term effect of budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial Lancet 353 1999 1819 1823
39. The Lung Health Study Research Group Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease N Engl J Med 343 2000 1902 1909
40. ER Sutherland H Allmers NT Ayas AJ Venn RJ Martin Inhaled corticosteroids reduce the progression of airflow limitations and chronic obstructive pulmonary disease: a meta-analysis Thorax 58 2003 937 941
41. FJ Martínez G Foster JL Curtis G Criner G Weinmann A Fishman Predictors of mortality in patients with emphysema and severe airflow obstruction Am J Respir Crit Care Med 173 2006 1326 1334
42. C Landbo E Prescott P Lange J Vestbo T Almidal Prognostic value of nutritional status in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1999 1856 1861
43. VM Pinto-Plata C Cote H Cabral J Taylor BR Celli The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Eur Respir J 23 2004 28 33
44. C Casanova C Cote JP de Torres A Aguirre-Jaime JM Marín V Pinto-Plata Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 171 2005 591 597
45. A Domingo-Salvany R Lamarca M Ferrer J García-Aymerich J Alonso M Félez Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 680 685
46. P Man JE Connett NR Anthonisen RA Wise DP Tashkin DD Sin C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease Thorax 61 2006 849 853
47. BR Celli CG Cote JM Marín C Casanova M Montes de Oca RA Méndez The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012
48. JJ Hospers DS Postma B Rijcken ST Weiss JP Schouten Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study Lancet 356 2000 1313 1317
49. J Vestbo EF Hansen Airway hyperresponsiveness and COPD mortality Thorax 56 Suppl 2 2001 11 14
50. O Díaz C Villafranca H Ghezzo G Borzone A Leiva J Milic-Emili Role of inspiratory capacity on exercise tolerance in COPD patients with and without expiratory flow limitations at rest Eur Respir J 16 2000 269 275
51. DE O'Donnell SM Revill KA Webb Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 770 777
52. AMWJ Schols J Slangen L Volovics Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1791 1797
53. A Fishman F Martínez K Naunheim S Piantadosi R Wise A Ries National Emphysema Treatment Trial Research group. A randomised trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema N Engl J Med 348 2003 2059 2073
54. O'Donnell T Flüge F Gerken A Hamilton K Webb B Aguilaniu Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 2004 832 840
55. D O'Donnell F Sciurba BR Celli DA Mahler K Webb CJ Kalberg Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD Chest 130 2006 647 656
56. M Decramer B Celli DP Tashkin RA Pauwells D Burkhart C Cassino Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the Uplift trial COPD 1 2004 303 312
57. RM Timms FU Khaja GW Williams The nocturnal oxygen trial group. Haemodynamic response to oxygen therapy in chronic obstructive pulmonary disease Ann Intern Med 102 1985 29 36
58. E Weitzenblum A Sautegeau M Ehrhart M Mammossesr A Pelletier Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease Am Rev Respir Dis 131 1985 493 496
59. M Tobiasz P Sliwiñsk I Hawrytiewicz G Patasiewicz J Zieliñski Pulmonary haemodynamics after 6 years of oxygen therapy in COPD Am J Respir Crit Care Med 151 1995 A255
60. D Górecka K Gorzelak P Sliwinski M Tobiasz J Zielinski Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia Thorax 52 1997 674 679
61. B Burrows RH Earle Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients N Engl J Med 280 1969 397 404
62. DS Postma J Burema F Gimeno JF May JM Smit EJ Steenhuis Prognosis in severe chronic obstructive pulmonary disease Am Rev Respir Dis 119 1979 357 367
63. R Keller A Ragaz P Borer Predictors of early mortality in patients with long-term oxygen home therapy Respiration 48 1985 216 221
64. CB Cooper J Waterhouse P Howard Twelve year clinical study of patients with hypoxic cor pulmonale given long-term domiciliary oxygen therapy Thorax 42 1987 105 110
65. J García-Aymerich P Lange M Benet P Schnohr JM Antó Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population-based cohort study Thorax 61 2006 772 778
66. K Skwarki W MacNee PK Wraith P Sliwinski J Zielinski Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy Chest 100 1991 1522 1527
67. SF Boushy HK Thompson LB North AR Beale TR Snow Prognosis in chronic obstructive pulmonary disease Am Rev Respir Dis 108 1973 1373 1383
68. A Aida K Miyamoto M Nishimura M Aiba S Kira K Kawakami Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy Am J Respir Crit Care Med 158 1998 188 193
69. T Neff TL Petty Tolerance and survival in severe chronic hypercapnia Arch Intern Med 129 1972 591 596
70. B Burrows LJ Kettel AH Niden M Rabinowitz CF Diener Patterns of cardiovascular dysfunction in chronic obstructive pulmonary disease N Engl J Med 286 1972 912 918
71. R Cooper J Ghali BE Simmons A Castaner Elevated pulmonary artery pressure Chest 99 1991 112 120
72. M Oswald-Mammosser E Weitzenblum E Quoix G Moser A Chaouat Cl Charpentier Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure Chest 107 1995 1193 1198
73. MI Burgess N Mogulkoc RJ Bright-Thomas P Bishop JJ Egan SG Ray Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic obstructive pulmonary disease J Am Soc Echocardiogr 15 2002 633 639
74. RA Incalzi L Fuso M De Rosa A di Napoli S Basso G Pagliari Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease Circulation 99 1999 1600 1605
75. L Nici Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease Clin Chest Med 21 2000 693 704
76. T Oga K Nishimura M Tsukino S Sato T Hajiro M Mishima Exercise capacity deterioration in patients with COPD. Longitudinal evaluation over 5 years Chest 128 2005 62 69
77. MV López Varela T Anido M Larrosa Estado funcional y supervivencia de los pacientes con EPOC tras rehabilitación respiratoria Arch Bronconeumol 42 2006 434 439
78. L Cahalin P Pappagianopoulos S Prevost J Wain L Ginns The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease Chest 108 1995 452 459
79. C Casanova CG Cote JM Marín JP de Torres A Aguirre-Jaime R Méndez The six-minute walk distance: long-term follow up in patients with COPD Eur Respir J 29 2007 535 540
80. R Peto FE Speizer AL Cochrane The relevance in adults of airflow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease Am Rev Respir Dis 128 1983 491 500
81. KL Ebi-Kryston Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all cause in the Whitehall study J Clin Epidemiol 41 1988 251 260
82. FJ Wiles E Hnizdo Relevance of airflow obstruction and mucus hypersecretion to mortality Respir Med 85 1991 27 35
83. WM Vollmer LE McCamant LR Johnson AS Buist Respiratory symptoms, lung function, and mortality in a screening center cohort Am J Epidemiol 129 1989 1157 1169
84. P Lange J Nyboe M Appleyard G Jensen P Schnohr The relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes Thorax 45 1990 579 585
85. R Pistelli P Lange DL Miller Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity Eur Respir J 21 Suppl 40 2003 10 14
86. 1 decline and COPD morbidity Am J Respir Crit Care Med 153 1996 1530 1535
87. E Prescott P Lange J Vestbo Chronic mucus hypersecretion in COPD and death from pulmonary infection Eur Respir J 8 1995 1333 1338
88. American Thoracic Society Dyspnea: mechanisms, assessment, and management; a consensus statement Am J Respir Crit Care Med 159 1999 321 340
89. CP Engström LO Persson S Larson A Ryden M Sullivan Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study Thorax 51 1996 825 830
90. M Ferrer J Alonso J Morera R Marrades A Khalaf MC Aguar Chronic obstructive pulmonary disease stage and health-related quality of life: the quality of life of chronic obstructive pulmonary disease study group Ann Intern Med 127 1997 1072 1079
91. F Kauffmann I Annesi J Chwalow Validity of subjective assessment of changes in respiratory health status: a 30 year epidemiological study of workers in Paris Eur Respir J 10 1997 2508 2514
92. TAR Seemungal GC Donaldson EA Paul JC Bestall DJ Jeffries JA Wedzicha Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1418 1422
93. JJ Soler L Sánchez P Román MA Martínez M Perpiña Risk factors of emergency care and admissions in COPD patients with high consumption of health resources Resp Med 98 2004 318 329
94. G Gudmundsson T Gislason E Lindberg R Hallin CS Ulrik E Brondum Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity Respir Res 7 2006 109
95. DA Gerardi L Lovett ML Benoit-Connors JZ Readrdon RL ZuWallack Variables related to increased mortality following out-patient pulmonary rehabilitation Eur Respir J 9 1996 431 435
96. C Esteban JM Quintana M Aburto J Moraza A Capelastegui A simple score for assessing stable chronic obstructive pulmonary disease QJM 99 2006 751 759
97. JJ Soler Cataluña El papel de las exacerbaciones en la historia natural de la EPOC Arch Bronconeumol 43 2007 55 58
98. H Gunen SS Hacievligyagil F Kosar LC Mutlu G Gulbas E Pehlivan Factors affecting survival of hospitalised patients with COPD Eur Respir J 26 2005 234 241
99. JV Lightowler JA Wedzicha MW Elliot FS Ram Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis BMJ 326 2003 185 189
100. PK Plant JL Owen MW Elliot Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome Thorax 56 2001 708 712
101. A Alsaedi DD Sin FA McAlister The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomised placebo-controlled trials Am J Med 113 2002 59 65
102. DD Sin L Wu JA Anderson NR Anthonisen AS Buist PS Burge Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease Thorax 60 2005 992 997
103. PM Calverley JA Anderson B Celli GT Ferguson C Jenkins PW Jones Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
104. P Calverley R Pauwels J Vestbo P Jones N Pride A Gulsuik Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial Lancet 361 2003 449 456
105. W Szafransky A Cukier A Ramírez G Menga R Sansores S Nahabedian Efficacy and safety of budesonide/formoterol and formoterol in chronic obstructive pulmonary diseases Eur Respir J 22 2003 912 918
106. DE Niewoehner K Rice C Cote D Paulson JA Cooper Jr L Kordicki Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial Ann Intern Med 143 2005 317 326
107. I Tille-Leblond CH Marquette T Pérez A Scherpereel C Zanetti AB Tonnel Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors Ann Intern Med 144 2006 390 396
108. JL Carson MA Kelley AE Duff JF Weg WJ Fulkerson HI Palevsky The clinical course of pulmonary embolism N Engl J Med 326 1992 1240 1245
109. JL Carson ML Terrin A Duff MA Kelley Pulmonary embolism and mortality in patients with COPD Chest 110 1996 1212 1219
110. M Modesto-Alapont D Nauffal-Manzur E Ansótegui-Barrera R Menéndez-Villanueva A Ballesta R Touza ¿Puede reducir la mortalidad de los pacientes con EPOC la profilaxis domiciliaria de la enfermedad tromboembólica venosa? Arch Bronconeumol 42 2006 130 134
111. K Gray-Donald L Gibbons SH Shapiro PT Macklem JG Martin Nutritional status and mortality in chronic obstructive pulmonary disease Am J Respir Crit Care Med 153 1996 961 966
112. S Martí X Muñoz J Ríos F Morell J Ferrer Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy Eur Respir J 27 2006 689 696
113. E Prescott T Almdal KL Mikkelsen CL Tofteng J Vestbo P Lange Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study Eur Respir J 20 2002 539 544
114. JJ Soler L Sánchez P Román MA Martínez M Perpiñá Prevalencia de la desnutrición en pacientes ambulatorios con enfermedad pulmonar obstructiva crónica estable Arch Bronconeumol 40 2004 250 258
115. C Coronell M Orozco-Levi A Ramírez-Sarmiento J Martínez-Llorens J Broquetas J Gea Prevalencia de la desnutrición en pacientes ambulatorios con enfermedad pulmonar obstructiva crónica estable Arch Bronconeumol 38 2002 580 584
116. MPKJ Engelen AMWJ Schols WC Baken GJ Wesseling EFM Wouter Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in an outpatient population with chronic obstructive pulmonary disease Eur Respir J 7 1994 1793 1797
117. EM Baarends AM Schols R Mosstert EF Wouters Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease Eur Respir J 10 1997 2807 2813
118. H Sahebjami E Sathianpitayakul Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 2000 886 890
119. R Shoup G Dalsky S Warner M Davis M Connors M Khan Body composition and health-related quality of life in patients with obstructive airways disease Eur Respir J 10 1997 1576 1580
120. K Marquis R Debigaré Y Lacasse P LeBlanch J Jobin G Carrier Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 809 813
121. AMWJ Schols R Broekhuizen CA Weling-Scheepers EF Wouters Body composition and mortality in chronic obstructive pulmonary disease Am J Clin Nutr 82 2005 53 59
122. J Vestbo E Prescott T Almdal M Dahl BG Nordestgaard T Andersen Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample. Findings from the Copenhagen City Heart Study Am J Respir Crit Care Med 173 2006 79 83
123. LP McGarvey M John JE Anderson M Zvarich R Wise Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical endpoint committee Torax 62 2007 411 415
124. DJ Hole GC Watt G Davey-Smith GL Hart GR Gillis VM Hawthorne Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study BMJ 313 1996 711 715
125. HJ Schunemann J Dorn BJ Grant W Winkelstein Jr M Trevisan Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study Chest 118 2000 656 664
126. DD Sin SF Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular disease? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519
127. DD Sin P Lacy E York SFP Man Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 760 765
128. L Huiart P Ernst X Ranouil S Suissa Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD Eur Respir J 25 2005 634 639
129. GJ Mancini M Etminan B Zhang LE Levesque M FitzGerald JM Brophy Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptors blockers in patients with chronic obstructive pulmonary disease J Am Coll Cardiol 47 2006 2554 2560
130. V Soyseth PH Brekke P Smith T Omland Statin use is associated with reduced mortality in COPD Eur Respir J 29 2007 279 283
131. A Chambellan E Chailleux T Similowski the ANTADIR observatory group Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy Chest 128 2005 1201 1208
132. R Broekhuizen EFM Wouters EC Creutzberg AMWJ Schols Raised CRP levels mark metabolic and functional impairment in advanced COPD Thorax 61 2006 17 22
133. P Joppa D Petrasova B Stancak R Tkacova Systemic inflammation in patients with COPD and pulmonary hypertension Chest 130 2006 326 333
134. JB Soriano JL Izquierdo EPOC en la vida y la muerte Arch Bronconeumol 42 2006 421 422
135. M Charlson P Pompei KL Ales CR MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chron Dis 40 1987 373 383
136. M Charlson TP Szatrowski J Peterson J Gold Validation of a combined index J Clin Epidemiol 47 1994 1245 1251
137. DD Sin NR Anthonisen JB Soriano AG Agustí Mortality in COPD: role of comorbidities Eur Respir J 28 2006 1245 1257
138. CG Cote BR Celli Pulmonary rehabilitation and the BODE index in COPD Eur Respir J 26 2005 630 636
139. S Imfeld KE Bloch W Weder EW Russi The BODE index after lung volume reduction surgery correlates with survival Chest 129 2006 873 878
140. BR Celli Predicting mortality in chronic obstructive pulmonary disease. Chasing the “Holy Grail” Am J Respir Crit Care Med 173 2006 1298 1299